R.F. Lafferty & Co., Inc. is acting as the sole book-running manager for the offering.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARTL:
- Artelo Biosciences presents interim Phase 2 CAReS data on ART27.13
- Artelo Biosciences Completes Stock Offering with Over-Allotment
- Artelo Biosciences announces publication of preclinical data on ART12.11
- Artelo Biosciences Updates Bylaws on September 9, 2025
- Alphabet downgraded, Boeing upgraded: Wall Street’s top analyst calls